Browsing by Author Dobrovic, Alexander

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2013BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV DamageKakavand, Hojabr; Mann, Graham; Scolyer, Richard; Thompson, John; Behren, Andreas; Cebon, Jonathan Simon; Dobrovic, Alexander; Kelly, John; Li, Jason; Mar, Victoria; McArthur, Grant A.; McLean, Catriona; Papenfuss, Anthony Troy; Tothill, Richard W.; Wolfe, Rory; Wong, Stephen; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: SurgeryBRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage, Clinical Cancer Research, vol.19, 17, 2013,pp 4589-4598
2012BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Emmanuel, Catherine; Alsop, Kathryn; Birrer, Michael; Bowtell, David D L; Dobrovic, Alexander; Fereday, Sian; Fox, Stephen B.; Friedlander, Michael; George, Joshy; Meldrum, Cliff; Mitchell, Gillian; Stewart, Colin; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteBRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.30, 21, 2012,pp 2654-2663
2010Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KITHamilton, Anne; Dobrovic, Alexander; Handolias, D; Kerr, L; McArthur, Grant A.; Moodie, K; Salemi, R; Tan, A; Central Clinical School: MedicineClinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT, British Journal of Cancer, vol.102, 8,pp 1219-1223
2010DNA methylation profiling of phyllodes and fibroadenoma tumours of the breastLee, Cheok; Dobrovic, Alexander; Fox, Stephen B; Huang, Katie T.; Karim, Rooshdiya; Lakhani, Sunil R.; Yan, Max; Central Clinical School: MedicineDNA methylation profiling of phyllodes and fibroadenoma tumours of the breast, Breast Cancer Research and Treatment, vol.124, 2,pp 555-565
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerPavlakis, Nick; Azad, Arun; Chong, Geoff; Dobrovic, Alexander; Fluck, Kate; Gebski, Val; Johns, Terrance G; Mariadason, John M; Price, Timothy; Salemi, R; Scott, Andrew M; Skrinos, Effie; Tebbutt, Niall; Weickhardt, Andrew J; Northern Clinical School: MedicineDual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer, Journal of Clinical Oncology, vol.30, 13, 2012,pp 1505-1512
2007High resolution melting for mutation scanning of TP53 exons 5-8deFazio, Anna; Ahmed Ashoure, Ahmed; Bowtell, David D L; Brenton, James D; Dobrovic, Alexander; Etemadmoghadam, Dariush; Fox, Stephen B; Hyland, Sarah; Krypuy, Michael; Western Clinical School: Westmead Millennium InstituteHigh resolution melting for mutation scanning of TP53 exons 5-8, BMC Cancer, vol.7,(open access),2007,pp 168-N/A
2015Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic valueArmstrong, Nicola Joy; Avery-Kiejda, Kelly A; Dobrovic, Alexander; et al, Various; Locke, W; Nair, S; Qu, Wenjia; Robinson, Mark D; Song, Jenny; Stirzaker, Clare; Stone, Andrew; Zotenko, Elena; Mathematics & StatisticsMethylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value, Nature Communications, vol.6, N/A, 2015,pp 1-11
2013Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutationsdeFazio, Anna; Alsop, Kathryn; Bowtell, David D L; Dobrovic, Alexander; Etemadmoghadam, Dariush; George, Joshy; Hondow, Heather; Levine, Douglas; Mikeska, Thomas; Mitchell, Gillian; Smyth, Gordon; Western Clinical School: Westmead Millennium InstituteNonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations, Clinical Cancer Research, vol.19, 13, 2013,pp 3474-3484